VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
MBRX
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
MBRXMoleculin Biotech, Inc.
$3.57$147M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksMBRXQuarterly Financials

Moleculin Biotech, Inc. (MBRX) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Moleculin Biotech, Inc. (MBRX) quarterly income statement — complete revenue, gross profit & net income history

MBRX Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Sales/Revenue00000000000000000000
Revenue Growth %--------------------
Cost of Goods Sold8K0029K031K00035K0000000000
COGS % of Revenue--------------------
Gross Profit-8K00-29K0-31K000-35K0000000000
Gross Margin %--------------------
Gross Profit Growth %-100%---11.43%--------------
Operating Expenses7.87M7.53M5.91M5.69M5.94M6.61M7.13M6.18M6.68M8.88M5.95M6.41M8.35M7.05M9.08M7.43M7.07M5.21M6.16M5.52M
OpEx % of Revenue--------------------
Selling, General & Admin2.49M2.41M2.15M2.09M2.48M2.16M2.17M2.06M2.39M2.25M2.63M2.49M2.64M2.84M3.09M3.2M2.42M1.99M2.02M2.43M
SG&A % of Revenue--------------------
Research & Development5.38M5.12M3.74M3.6M3.44M4.46M4.93M4.09M4.25M6.63M3.28M3.89M5.69M4.18M5.96M4.2M4.62M3.18M4.09M3.04M
R&D % of Revenue--------------------
Other Operating Expenses8K9K21K031K031K31K32K032K31K30K32K32K34K32K34K41K44K
Operating Income-7.87M-7.53M-5.91M-5.72M-5.94M-6.64M-7.13M-6.18M-6.68M-8.92M-5.95M-6.41M-8.35M-7.05M-9.08M-7.43M-7.07M-5.21M-6.16M-5.52M
Operating Margin %--------------------
Operating Income Growth %-32.49%-13.4%17.22%7.52%10.99%25.52%-19.98%3.53%20.07%-26.55%34.53%13.76%-18.09%-35.41%-47.54%-34.75%-16.2%-48.93%-0.1%-9.59%
EBITDA-7.87M-7.52M-5.88M-5.69M-5.91M-6.61M-7.1M-6.15M-6.64M-8.88M-5.92M-6.38M-8.32M-7.02M-9.05M-7.4M-7.04M-5.17M-6.12M-5.47M
EBITDA Margin %--------------------
EBITDA Growth %-33.05%-13.79%17.16%7.52%11.03%25.57%-20.06%3.54%20.17%-26.62%34.64%13.78%-18.21%-35.68%-48.03%-35.21%-16.51%-49.93%-0.33%-9.86%
D&A (Non-Cash Add-back)8K9K22K29K31K31K32K31K32K35K31K31K30K32K32K34K32K34K42K44K
EBIT-7.87M-7.53M-5.91M-7.64M-5.94M-1.88M-7.13M-6.18M-6.68M-10.27M-5.95M-6.41M-8.35M-7.05M-9.08M-7.43M-7.07M-5.21M-6.16M-5.52M
Net Interest Income34K9K39K26K30K47K102K159K241K262K324K390K392K126K33K39K42K70K87K92K
Interest Income34K9K39K26K30K47K102K159K241K262K324K390K392K126K33K39K42K70K87K92K
Interest Expense0000000000000-000000
Other Income/Expense-4.97M23.09M-19.49M-1.92M-493K4.76M-3.46M1.87M1.71M-1.35M338K435K439K278K473K657K207K2.38M1.78M1.27M
Pretax Income-12.85M15.55M-25.4M-7.64M-6.44M-1.88M-10.59M-4.32M-4.97M-10.27M-5.61M-5.98M-7.92M-6.77M-8.61M-6.78M-6.87M-2.83M-4.38M-4.24M
Pretax Margin %--------------------
Income Tax00000000000000000000
Effective Tax Rate %0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%
Net Income-12.85M15.55M-25.4M-7.64M-6.44M-1.88M-10.59M-4.32M-4.97M-10.27M-5.61M-5.98M-7.92M-6.77M-8.61M-6.78M-6.87M-2.83M-4.38M-4.24M
Net Margin %--------------------
Net Income Growth %-99.58%926.35%-139.79%-76.89%-29.5%81.67%-88.84%27.73%37.21%-51.68%34.86%11.82%-15.26%-139.65%-96.64%-59.68%-54.49%-7.05%-28.98%58.03%
Net Income (Continuing)-12.85M15.55M-25.4M-7.64M-6.44M-1.88M-10.59M-4.32M-4.97M-10.27M-5.61M-5.98M-7.92M-6.77M-8.61M-6.78M-6.87M-2.83M-4.38M-4.24M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)-3.544.83-17.00-12.25-1722.00-14.00-71.25-42.50-50.50-128.25-70.50-75.50-96.50-73.75-112.25-89.00-87.50-37.00-57.50-56.00
EPS Growth %99.79%134.5%76.14%71.18%-3309.9%89.08%-1.06%43.71%47.67%-73.9%37.19%15.17%-10.29%-99.32%-95.22%-58.93%-14.38%56.85%53.72%85.36%
EPS (Basic)-3.544.83-17.00-12.25-1722.00-14.00-71.25-42.50-50.50-128.25-70.50-75.50-96.50-73.75-112.25-89.00-87.50-37.00-57.50-56.00
Diluted Shares Outstanding41.24M11.85M1.49M621.06K3.74K135.16K148.57K101.73K98.65K80.13K79.49K79.17K76.67K76.34K76.34K76.22K76.21K76.21K76.2K75.87K
Basic Shares Outstanding41.24M11.85M1.49M621.06K3.74K135.16K148.57K101.73K98.65K80.13K79.49K79.17K76.67K76.34K76.34K76.22K76.21K76.21K76.2K75.87K
Dividend Payout Ratio--------------------